1 / 10

30th November 2013 3rd iFAD– Maltron Satellite Symposium Ester Philipse

P16: Non-invasive hemodynamic monitoring with Nexfin in critically ill patients: a preliminary study. 30th November 2013 3rd iFAD– Maltron Satellite Symposium Ester Philipse. Introduction. Nexfin monitor (BMEYE, Amsterdam, the Netherlands) Non-invasive hemodynamic monitoring tool

peyton
Télécharger la présentation

30th November 2013 3rd iFAD– Maltron Satellite Symposium Ester Philipse

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. P16: Non-invasive hemodynamic monitoring with Nexfin in critically ill patients:a preliminary study 30th November 2013 3rd iFAD– Maltron Satellite Symposium Ester Philipse

  2. Introduction • Nexfin monitor (BMEYE, Amsterdam, the Netherlands) • Non-invasive hemodynamic monitoring tool • Finger blood pressure waveform • Volume-clamp principle of Penaz • Physiological and physical criteria of Wesseling

  3. Nexfin (BMEYE, Amsterdam, the Netherlands)

  4. Aim Validation of the Nexfin in a mixed population of medical ICU patients

  5. Methods • Prospective study in ICU patients • Comparing parameters obtained by Nexfin with PICCO monitoring, radial line or NIBP measurement by armcuff • Statistical analysis: Student t-test, Pearson correlation and Bland-Altman analysis,

  6. Results • 77 medical ICU patients were included In 7 patients measurement with Nexfin was not possible (excluded)

  7. Results – cardiac output

  8. Results – MAP

  9. Results – hemoglobin (Massimo-technique)

  10. Conclusion • MAP could be monitored non-invasively with Nexfin • CO measured by Nexfin is not correlating well with golden standard • Hemoglobin measured by Nexfin is not correlating well with hemoglobin obtained by blood analysis • The exact patient profile still had to be determined

More Related